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To better understand dynamic disease processes, integrated multi-omic methods are
needed, yet comparing different types of omic data remains difficult. Integrative solutions
benefit experimenters by eliminating potential biases that come with single omic analysis.
We have developed the methods needed to explore whether a relationship exists between
co-expression network models built from transcriptomic and proteomic data types, and
whether this relationship can be used to improve the disease signature discovery process.
A naïve, correlation based method is utilized for comparison. Using publicly available
infectious disease time series data, we analyzed the related co-expression structure of
the transcriptome and proteome in response to SARS-CoV infection in mice. Transcript
and peptide expression data was filtered using quality scores and subset by taking
the intersection on mapped Entrez IDs. Using this data set, independent co-expression
networks were built. The networks were integrated by constructing a bipartite module
graph based on module member overlap, module summary correlation, and correlation
to phenotypes of interest. Compared to the module level results, the naïve approach is
hindered by a lack of correlation across data types, less significant enrichment results,
and little functional overlap across data types. Our module graph approach avoids these
problems, resulting in an integrated omic signature of disease progression, which allows
prioritization across data types for down-stream experiment planning. Integrated modules
exhibited related functional enrichments and could suggest novel interactions in response
to infection. These disease and platform-independent methods can be used to realize
the full potential of multi-omic network signatures. The data (experiment SM001) are
publically available through the NIAID Systems Virology (https://www.systemsvirology.org)
and PNNL (http://omics.pnl.gov) web portals. Phenotype data is found in the supplementary
information. The ProCoNA package is available as part of Bioconductor 2.13.
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INTRODUCTION
Statistical and computational methods are used in systems biol-
ogy to infer underlying networks associated with disease (Aderem
et al., 2011). Networks can be used for deriving predictive sig-
natures of disease progression or severity, as well as helping to
elucidate the underlying mechanisms (Zak and Aderem, 2009).
A primary objective in systems biology is to understand the
structure and connection between the diverse biological elements
composing the living system, and how they dynamically change
and interact in response to biologically important events, such as
the host response to infection (Forst, 2006).
Single data-type signatures and biomarkers have found mixed
success where many potentially useful biomarkers have not
been validated (Ntzani and Ioannidis, 2003; Feng et al., 2004;
Brenner and Normolle, 2007; Hughes, 2009; Bhavsar et al.,
2010; Kint et al., 2010; Sturdevant et al., 2010). In virology,
biomarkers could be used to predict the host response, allow-
ing for earlier care, before the onset of extreme and dam-
aging cytokine responses (Davey et al., 2013). The biomarker
discovery process can utilize a range of different data types
including genomic (DNA sequence data), transcriptomic (gene
expression), proteomic (protein levels), metabolomics (metabo-
lite levels), and prior biological knowledge such as that found
in interactomics (encompassing protein-protein interactions
databases).
It is thought that predictors or biomarkers utilizing multiple
data types and/or exploiting the underlying network structure
will prove more robust, as these more reflect the complex biol-
ogy involved (Sung et al., 2012). A range of integration tech-
niques have been suggested including machine learning methods
(Lanckriet et al., 2004; Zhang et al., 2006; Daemen et al., 2008),
probabilistic networks (Hartemink et al., 2002; Troyanskaya et al.,
2003; Gat-Viks et al., 2006; Vaske et al., 2009), correlation net-
works (Adourian et al., 2008), statistical models (Nie et al., 2006;
Fagan et al., 2007; Lê Cao et al., 2008; Torres-García et al.,
2009), clustering techniques (Cancer Genome Atlas Network,
2012; Waters et al., 2012) and applications of spectral theory
(Berger et al., 2006; Tan et al., 2009; Kim et al., 2012). To produce
integrated network signatures, however, methods must be applied
across extremely heterogeneous sources, which has proven dif-
ficult because of the extreme differences between data types. In
particular, the integration of the transcriptome and proteome is a
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current challenge in omics research due to differences in dynamic
range of measurements, incomplete annotation, isoform differ-
ences, and temporal effects, as several examples (Cox et al., 2005;
Waters et al., 2006a,b; Cancer Genome Atlas Network, 2012).
We have developed the methods needed to explore whether a
relationship exists between co-expression network models built
from transcriptomic and proteomic data types, and whether
this relationship can be used to improve the disease signature
discovery process. This work uses publically available data from
an NIAID systems biology consortium study involving infec-
tion of SARS-CoV in mice. We have developed an approach to
produce integrated network signatures of disease by leveraging
earlier work on co-expression transcriptome networks (Zhang
and Horvath, 2005; Yip and Horvath, 2007; Mason et al., 2009;
Langfelder et al., 2008, 2011; Langfelder and Horvath, 2012)
and our own work in proteomic co-expression networks (Gibbs
et al., 2013). The signature consisted of a bipartite module graph,
connecting co-expression modules obtained from transcriptomic
and proteomic data, that is constructed using significant mod-
ule member overlap, correlation of eigenvector summaries, and
common phenotypic associations with outcomes of interest. The
functional enrichment of module sub-graphs was overlapping
across data types, further offering evidence of the underlying
biological network structure. This work provides a framework
for multi-omic prioritization of module members for biomarker
studies as well as perturbation and validation experiments (see
Figure 1).
METHODS
EXPERIMENTAL DATA
This publically available data (https://www.systemsvirology.org,
experiment SM001) was generated from 20-week-old C57/B6
mice infected with the MA15 mouse adapted SARS-CoV virus
(Roberts et al., 2007). In total, transcript and proteomic
expression profiles were collected for 92 mice representing four
dosage levels (102, 103, 104, 105 PFU) over four time points (1,
2, 4, 7 days), including 3 mock samples per day (5 mice ∗ 4 time
points ∗ 4 dose levels + 3 mocks ∗ 4 time points).
The control mouse at Day 7, replicate 2, and infected mouse
(PFU 102), Day 4, replicate 3, were removed from the study
since in the transcript data, the mice clustered with the incorrect
infection label.
Phenotype data quantified the pathological severity result-
ing from infection (see Gibbs et al., 2013 for more on
the phenotype data. The phenotype data can be found in
Supplementary Table 3). While the difference in pathology level
among the viral dosages is small, there was some observed differ-
ence in the kinetics of infection. Higher doses prompted more
immediate responses. The difference in pathology among the
viral dosages is relatively small. In total, 15 phenotype vari-
ables were recorded including an aggregate measure called the
“overall pathology score.” Many of the phenotype variables are
highly correlated, such as inflammation, airspace inflammation,
and interstitial inflammation. Other phenotype variables include
physical characteristics such as diffuse alveolar damage (DAD),
debris, edema, and hyaline membranes. Day and dose are also
included in the analysis.
TAKING THE PEPTIDE-TRANSCRIPT INTERSECTION
Using the VIPER software (v3.48) (Monroe et al., 2007) peptides
are matched to an Accurate Mass and Time (AMT) tag database
(Zimmer et al., 2006). Details are given on the systemsvirol-
ogy.org site and in Gibbs et al. (2013). Abundance measurements
for 16,890 peptides mapping to 3277 proteins were recorded for
184 LC-MS runs. Taking all observed peptides, protein inference
was performed using the Fido protein inference model (Serang
et al., 2010; Serang and Noble, 2012). Inferred Proteins were
accepted with scores above 0.95. From the total set of proteins,
691 proteins had this score or better.
Peptide data was filtered by peptide matching quality scores
(given by the VIPER software) STAC (>0.6), UP (>0.5), and
Peptide Prophet tag score (>0.9), which resulted in a matrix
of 184 sample rows by 9326 peptides. Sample replicates were
combined by taking the mean over replicates.
A second round of filtering was performed by assessing the
quantity of missing data. Missing data are encountered when pep-
tides are identified in a subset of samples. “Missingness filtration”
involves removing any peptide with greater than X%missing data
across samples. Peptides were filtered by missingness, taking pep-
tides with not more than 20% missing data, resulting in a matrix
of 90 samples by 2273 peptides. This process eliminates a large
proportion of the measured peptides (86.5%), however, for sta-
tistical analysis that depends on nearly complete matrices, many
peptides are unusable since they are identified in a very small
number of samples.
Thematchedmicroarray data were processed using the Agilent
Preprocess Bioconductor package (Lopez-romero, 2010). After
considering quality measures, 31,416 probes passed probe QC
flags for all replicates of at least one infected time point.
In order to focus on the dynamic relationship between the
transcriptome and proteome, the two data types were subset using
the intersection based upon Entrez gene IDs. Transcript probes on
the gene microarray were mapped to Entrez gene IDs using anno-
tation databases (mgug4122a.db) found in Bioconductor (2.11).
Proteins in the AMT tag database were mapped to Entrez IDs and
protein families using the Uniprot web service (Apweiler et al.,
2004; Wu et al., 2006; Magrane and Consortium, 2011).
Networks were constructed using intersection between quality
filtered peptide and transcript data. This corresponded to 90 total
samples with 2205 peptides mapping to 445 Uniprot IDs (in the
mass tag database) and 490 Entrez gene IDs. These gene IDs were
used to select transcript probes, resulting in 814 probes that corre-
sponded to 439Uniprot IDs and 447 Entrez gene IDs. Between the
two data sets, 437 Entrez IDs are shared. Some discrepancy was
observed, since peptides are often degenerate, mapping to mul-
tiple proteins, creating a scenario in which an entry maps from
a given Uniprot ID to multiple Entrez IDs. To address mapping
discrepancies, after mapping to Entrez IDs, only IDs contained
within the intersection were considered.
CONSTRUCTING THE INTEGRATED BIPARTITE MODULE GRAPHS
Network based integration of transcript and peptide data was per-
formed by constructing independent co-expression networks for
each data type using methods derived fromWGCNA. (Langfelder
and Horvath, 2008; Mason et al., 2009; Iancu et al., 2012a).
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FIGURE 1 | Prioritization of integrated data leading to a multi-omic
integrated co-expression signature for SARS-CoV infection. Given mice
infected with a mouse adapted SARS-CoV virus, transcript (gene microarray)
and peptide (LC-MS) data are collected from lung tissue. The data is used to
construct independent co-expression networks for each data type. Using
three metrics, transcript and peptide modules are compared and joined,
producing a bipartite module graph. In the module graph, two kinds of edges
are shown. Solid edges indicate a significant correlation between module
eigenvectors. Dashed edges indicate significant overlap in terms of module
membership. Node sizes correspond to the size of the module and node
outlines show the direction of correlation compared to the degree of lung
pathology (the overall-pathology-score).
Co-expression networks are composed of nodes connected by
weighted edges. Edge weights were computed using signed, robust
correlations producing a similarity matrix (Langfelder et al.,
2012). The similarity matrix raised to a power, beta, produces
the adjacency matrix. Beta was selected according to scale-free
model criterion (R2 describes the model fit), peptide networks
had an R2 greater than 0.8 and transcript networks greater than
0.9. The adjacency matrix is used to compute topological overlap
between nodes, weighting the network edges. Topological overlap
is defined as TOMij = (lij + aij)/[min(ki, kj) + 1 − aij] where lij
is the dot product on row i and column j in adjacency matrix [a]
and ki (the connectivity) is the summation of row i in adjacency
matrix [a].
Groups of nodes were partitioned into subnetworks, or
modules, containing (in this case) either transcripts or pep-
tides. Modules were composed of strongly connected (high edge
weights) nodes. The dynamic hybrid treecut method was used to
derive subnetworks or modules (Langfelder et al., 2008), using
default settings.
Modules were summarized by taking the first right-singular
vector produced by singular value decomposition on expression
data represented by nodes contained in the module. The module
eigenvectors (MEs or module summaries) allowed us to associate
modules to biological phenotypes using correlation. Modules
were labeled numerically according to decreasing size, module 1
being the largest.
Although the hybrid treecut algorithm generally works well,
there is no guarantee for a module’s average connectivity to be
greater than what is expected by random. Permutation testing was
used to assess module significance by comparing the mean topo-
logical overlap of nodes within a module to the mean topological
overlap of a randomly sampled set of nodes equal in size to the
module being tested. This is equivalent to permuting the module
labels on nodes. Ten thousand permutations were performed.
Finally, to build the bipartite module graph, the first step
involved measuring the member overlap between all pairs of
modules (peptide-transcript). To test the significance of over-
laps, randommodules were constructed, keeping themodule sizes
fixed (equivalent in size to our derived modules) and varying the
contents. Ten thousand permutations were performed. The count
of permuted overlaps larger than the observed was used as an
empirical p-value. Significant overlaps were used as edges between
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modules if FDR adjusted p-values were less than 0.1. This relaxed
threshold was picked to increase sensitivity.
The edges of the bipartite graph are filtered by correlation
between eigenvector summaries. The connection between mod-
ule eigenvectors was measured using the Pearson correlation.
Using Bonferroni multiple testing correction, p-values less than
0.0006 [0.05/(14 peptide modules ∗ 6 transcript modules)] were
accepted. If deemed appropriate, edges could be retained with-
out significant overlap, as long as the annotation reflects that.
The third step involved filtering edges by comparing the joined
modules association to a phenotype. Edges were kept if the
eigenvector-phenotype association was in the same direction and
adjusted p-values were less than 0.05.
The combination of these three measures—member overlap,
eigenvector correlation, and similar phenotype associations—
constructed an integrated bipartite module graph that describes
an integrated signature.
Functional enrichment via Gene Ontology terms was per-
formed using the GOstats package (Ashburner et al., 2000; Falcon
and Gentleman, 2007). The universe consisted of the 5521 Entrez
IDs found in mass tag database, the limiting factor on pep-
tide identifications. The conditional method was used which
minimizes the correlation between GO terms. P-values were
adjusted using the Benjamini and Yekutieli method (Benjamini
and Yekutieli, 2001).
NAÏVE METHOD BASED ON CORRELATION FOR COMPARISON TO THE
MODULE LEVEL ANALYSIS
A Pearson correlation based naïve approach was designed for
comparison to the module level analysis. The approach involved
computing correlations—independently for each peptide and
transcript—on the overall pathology score phenotype. This pro-
duced two ranked lists for peptides and transcripts, each with
both positive and negative correlations. The naïve top ranked
entities were compared to the rankings within modules.
For comparison to the enrichment results, members of the
ranked lists were selected from the most negative and most pos-
itive correlations separately, with size equal to the mean module
sizes for the peptide and transcript networks (151 peptides and
130 transcripts). These selections were used for gene ontology
enrichment using the same method as described in Constructing
the Integrated Bipartite Module Graphs.
RESULTS
CHARACTERIZATION OF THE CO-EXPRESSION NETWORKS OBTAINED
FROM SINGLE OMIC DATA TYPES
The transcript network consisted of 6 modules containing
between 42 and 357 transcripts. The peptide network consisted
of 14 modules containing between 70 and 316 peptides. The
modules were labeled numerically in order of decreasing size.
Each co-expression network independently showed significant
Pearson correlations between the module eigenvectors and phe-
notype data (See Supplementary Figures 1 and 2). In both net-
works, the greatest positive correlation was found with day of
infection (transcript module 3, r = 0.84, peptide module 10,
r = 0.70). When inflammation related variables were considered
(inflammation, airspace inflammation and interstitial septum
inflammation) transcript module 3 and peptide module 2 showed
the strongest correlations (inflammation, transcript module 3,
R = 0.6, peptide module 2, R = 0.6). These modules also showed
the strongest correlation with the overall pathology of the mice.
Conversely, transcript module 1 and peptide module 4 showed
the same pattern of associations with phenotype as transcript
module 3 and peptide module 2, but with negative correlations.
Members of these modules had abundance profiles that decreased
over time. In contrast to the previous two patterns of association,
transcript module 4 and peptide module 12 were more associated
with the administered viral dosage instead of day of infection. The
modules showed strong associations with denudation, debris, and
airway pathology whereas the previous two module sets did not.
INITIAL CONSTRUCTION OF THE BIPARTITE MODULE GRAPH BY
OVERLAP OF MODULE MEMBERS
Significant module member overlaps were observed between the
two co-expression networks. Overlaps were represented as a count
of similar Entrez gene IDs (after mapping). Using permutation
testing we ascertained whether the size of the overlap was larger
that what is expected by chance. Permutation test significance was
defined as FDR adjusted p-values less than 0.1. By that definition,
ten out of 84 possible significant module overlaps were observed,
forming three distinct sub-graphs, initializing the bipartite mod-
ule graph. Overlaps were quantified by taking |Intersection(A,B)|/
min[size(A), size(B)]. Transcript module 1 overlapped with pep-
tide modules 1, 4, and 8 (overlap amounts of 0.33, 0.39, and 0.42
with FDRs 0.0, 0.08, and 0.016 respectively). Transcript module
2 overlapped with peptide modules 2 and 3 (overlap amounts of
0.38 and 0.35 with FDRs 0.016 and 0.041 respectively). Transcript
module 3 overlapped with peptide modules 2, 3, 5, and 10 (over-
lap amounts of 0.37, 0.38, 0.31, and 0.26 with FDRs of 0.068,
0.016, 0.087, and 0.016 respectively), and lastly, transcript module
4 overlapped with peptide module 12 (overlap amount 0.11, FDR
0.080). These overlaps formed the initial edges of the bipartite
module graph.
MODULE EIGENVECTOR CORRELATION CONFIRMS AND ADDS EDGES
TO THE BIPARTITE GRAPH
From the 10 edges in the overlap graph, eight showed signif-
icant eigenvector correlation after Bonferroni multiple testing
correction (p-values < 0.0006; See Supplementary Figure 3).
Summarizing the results: the Pearson correlations between tran-
script module 1 and peptide modules 4 and 8 were 0.523 and
0.434 respectfully (p-values 1.16e-07 and 1.908e-05). The cor-
relation between transcript module 4 and peptide modules 12
and 13 was 0.696 and 0.683 (p-values 1.159e-13 and 2.554e-
14). The correlation between eigenvectors of transcript module
3 and peptide modules 2 and 10 was 0.755 and 0.801 (p-value
2.2e-16 for both). A particularly interesting case is seen with tran-
script module 4 and peptide module 13, where module overlap
is not observed, but a strong connection between module eigen-
vectors is present. This encouraged us to include an additional
edge between these modules. These cases are potentially very
interesting connections, where connected modules are driven by
unmatched hubs in the network, which might imply previously
unknown interactions.
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ADDITIONAL EDGE CONFIRMATION WITH SHARED PHENOTYPE
ASSOCIATIONS
The bipartite module graph can be further modified by compar-
ing independent module associations to a phenotype of interest.
Strong correlation between eigenvectors typically brings a shared
correlation to sample phenotypes due to the similar vector struc-
tures. However, correlation is not transitive, which explains why
this should be accounted for, because if two module eigenvectors
correlate, it does not mean the two modules both correlate to a
given phenotype.
Considering only the overall pathology score phenotype, tran-
script module 3 and peptide module 2 remained connected.
Transcript module 4 and peptide modules 12 and 13 also demon-
strated strong shared phenotype associations. Transcript module
1 and peptide modules 4 and 8 shared negative correlations with
the overall pathology. These associations reinforced the bipar-
tite graph structure. Edges that did not reflect this similarity in
phenotype associations were removed.
The rich set of phenotypes was used to prioritize the
bipartite sub-graphs. We briefly describe an algorithm to pri-
oritize module sub-graphs, given a set of phenotypes: initial-
ize an n by m matrix where n is the number of transcript
modules and m is the number of peptide modules. For each
phenotype, the maximum and minimum (i.e., negative cor-
relation) correlating modules from each data type are found.
For each pair of modules in the matrix, and for each pheno-
type, if a pair of modules is maximum, +1 is added to the
matrix element corresponding to this pair, and if the mod-
ule pair has the minimum correlation, a −1 is added to
the matrix position corresponding to the pair (see Figure 2
and Supplementary_Network_Results). In some cases, a module
could arrive at a final summed score of 0 by alternatively win-
ning both negative and positive correlations. Therefore, it might
be necessary to keep scores strictly positive. This would return
the maximum score by magnitude, without regard to direction,
as an alternative prioritization procedure. After the prioritiza-
tion routine, the set of biologically relevant multi-omic modules
is ranked, providing a clear path toward targeted, downstream,
analysis.
MODULE SUB-GRAPHS SHOW TEMPORAL TRENDS
The peptides and transcript expression profiles, within a module
sub-graph, showed two types of temporal patterns. The expres-
sion response either varied with time or with viral dosage. The
patterns are made clear after collapsing the eigenvector sum-
maries by day (see Figure 3).
The first row of Figure 3 shows the abundance peaks of tran-
script module 3 and peptide module 2. Baseline abundance is
observed on day 1 followed by abundance increases over the
course of infection.
The second type of trend is exemplified by transcript module 1
with peptide modules 4 and 8, as well as transcript module 4 with
peptide modules 12 and 13. This trend showed a response pattern
associated with viral dosage rather than time. This is clearly seen
in the high dose column. In summary, we have found two dif-
ferent patterns of module response, one by time (increasing over
time) and the other by dosage.
FIGURE 2 | Module graph prioritization by examination of the
relationship of module-pairs to all phenotypic variables. Clear patterns
show transcript module 1 and peptide module 4 with the bulk of maximum
negative correlations and transcript module 3 and peptide module 2 with
the bulk of maximum positive correlations with the phenotype. This matrix
clearly provides ranking on sub-graphs.
SUB-GRAPHS SHARE FUNCTIONAL ANNOTATIONS
After sub-graph prioritization, we were interested in what bio-
logical entities were most central (i.e., correlated with the mod-
ule eigenvector) in the network modules. By filtering module
members by centrality, we have a metric by which to rank and
prioritize the module members. Taking the ten most central
module elements and using Uniprot web services, we exam-
ined the associated protein families. For transcript module 1
and peptide module 4, shared families included the Caveolin
family, GST superfamily, Mu family, Cu-Zn superoxide dis-
mutase family and transcript module 4 contained members
of the aldehyde dehydrogenase family. These protein fami-
lies are associated with metal binding proteins, interactions
with DNA and engaging in changes to acetylation patterns.
Putative caveolin-binding sites have been observed in SARS-
CoV encoded proteins, and aldehyde dehydrogenases have been
found to have a role in infection (Cai et al., 2003; Cinatl et al.,
2004).
In transcript module 3, central members included proteins
from the CAP family, Histone H1/H5 family, Histone H2A family,
and the intermediate filament family, while for peptide module 2
protein families included the GTP-binding elongation factor fam-
ily, the EF-Tu/EF-1A subfamily, the heat shock protein 90 family,
the Histone H1/H5 family, and the DEAD box helicase family
(eIF4A subfamily). Both histones and elongation factors have pre-
viously been associated with SARS-CoV infection (Reghunathan
et al., 2005).
Transcript module 4 and peptide modules 12 and 13 were
enzyme-driven and were associated with Serpin family members,
which are protease inhibitors. This is potentially important since
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FIGURE 3 | Overlapping eigenvector summaries show similar
response patterns observed across transcript and peptide
modules. The blue lines show collapsed transcript module
eigenvectors plotted over days post infection. Red dotted lines show
the collapsed peptide module eigenvectors. The top row shows the
module sub-network of transcript module 3 and peptide module 2.
The middle row shows transcript module 4 and peptide modules 12
and 13. The bottom row shows transcript module 1 with peptide
modules 4 and 8. There is clear evidence of a shared response
between transcript and peptide modules, demonstrating a multi-omic
signature. See the supplementary tables for lists of the drivers and
enriched functional categories.
it was recently reported that—along with Serpin1—the coag-
ulation and urokinase pathways are activated during infection.
(Gralinski et al., 2013). This is closely related to lung pathol-
ogy involving disseminated small vessel thromboses in the lungs
(Ng et al., 2004a,b; de Lang et al., 2007). This module sub-graph
could be used for further examining the systems level connection
between omics and pathology.
Examination of significant GO terms shows largely similar
trends compared to protein family annotations (all adjusted
p-values are Bonferroni adjusted p-values). For transcript mod-
ule 1 and peptide modules 4 and 8, the most significant over-
lapping GO terms include processes involving actin filament
processes (“actin filament-based movement,” transcript mod-
ule 1, adj. p-value 5.51e-05, “actin cytoskeleton organization,”
peptides modules 4 and 8, adj. p-values 5.84e-02 and 4.11e-03
respectively), component assembly (“protein complex assembly,”
transcript module 1, adj. p-value 1.09e-02, “cellular component
assembly,” peptides module 4, adj. p-values 3.93e-07). It has been
observed that SARS-CoV infection induces structural changes
involving actin reorganization (Ng et al., 2004a,b; Surjit et al.,
2004).
Transcript module 3 and peptide module 2 have a num-
ber of overlapping enriched GO terms including “nucleosome
assembly” (transcript module 3, adj. p-value 9.66e-05, peptides
module 2, adj. p-value 2.37e-05), and “protein-DNA complex
subunit organization” (transcript module 3, adj. p-value 2.63e-
03, peptide module 2, adj p-value 2.58e-04). Also, shared terms
include “cellular component assembly” (transcript module 3, adj.
p-value 5.48e-05, peptides module 2, adj. p-value 5.00e-05), and
“cellular macromolecular complex assembly” (transcript mod-
ule 3, adj. p-value 5.80e-05, peptides module 2, adj. p-value
4.71e-09). These functional associations again point to structural
changes (Reghunathan et al., 2005).
In transcript module 4, peptide module 12 and peptide mod-
ule 13, enriched GO terms associated with the regulation of
processes. In particular, the “negative regulation of endopepti-
dase” (transcript module 1, adj. p-value 5.59-02, peptides mod-
ules 12 and 13, adj. p-values 8.36e-15 and 4.76e-06 respectively).
Although, the transcript module is not highly significant when
considering Bonferroni adjusted p-values, the GO term over-
lap between modules is strong here. Clearly endopeptidases,
hydrolases, and cytokines have important roles in SARS-CoV
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infection (Loureiro and Ploegh, 2006). Cystatins, one of the
represented protein families, has been proposed as a potential
therapeutic target (Leung-Toung et al., 2006).
Overall, each set of integrated modules was overlapping in
its functional annotation. Similarity in annotation between con-
nected modules of different data types adds further evidence of
true biological connection.
INTEGRATION OF MODULE SUB-GRAPHS LEADS TO RICHER RESULTS
A motivating use case for this approach was to develop a frame-
work for integrated, network-based prioritization of targets for
perturbation and validation. We compared the module level
results to those attained by use of a naïve correlation-based
method.
The naïve results took the form of two ranked lists for each data
type. In the lists, there were both negative and positive correla-
tions to the overall pathology phenotype. After mapping peptides
and transcripts to Entrez IDs, correlation to the overall pathology
phenotype, and the correlation between data types was compared
(See Supplementary Figure 4). While some peptide-transcript
pairs showed both strong correlation to the phenotype and
strong correlation across data types, 33.1% of peptide-transcript
pairs were essentially uncorrelated (across data type correla-
tion, −0.1 < r < 0.1), and 4.6% of peptide-transcript pairs were
anti-correlated (r < −0.3).
The naïve top ranked peptides and transcripts were not nec-
essarily the most central within a given module. In transcript
module 1, the most central (by correlation to the module eigen-
vector) was ranked 4th in the list of positive correlations. The
next two top ranked module transcripts were not in the naïve
top 10. On the peptide side, in module 4, the top ranked peptide
was ranked 10th in the naïve list. This is due to the fact that the
module construction is independent of any phenotype measure-
ment. Module structure is a result of entities sharing a pattern of
expression, rather than sharing a correlation with some external
measurement.
The naïve results showed a reduction in significance compared
to the module level tests. Four sets were taken from the ranked
lists: 151 positively correlated peptides (PCP), 151 negatively
correlated peptides (NCP), 130 positively correlated transcripts
(PCT), and 130 negatively correlated transcripts (NCT). The
results are listed in Supplementary Table 1. The PCP set of 151
peptides resulted in four significant GO terms, with Bonferroni
adjusted p-values ranging from 2.67e-03 to 2.55e-02. The NCP
set showed no significant GO term enrichment after Bonferroni
adjustment. On the other hand, the PCT set of 130 transcripts
showed 16 significant GO terms, with Bonferroni adjusted p-
values in the range of 9.14e-11 to 2.24e-02. The NCT set showed
three significant GO terms, Bonferroni p-value range of 2.61e-04
to 1.29e-02.
Two of the four significant GO terms found in the PCP
set were also found in the PCT set (“protein polymer-
ization” and “cellular macromolecular complex assembly”).
However, one GO term, “cellular response to interleukin-4”
(adj. p-value 2.67e-03), was not found in the enrichment
results for both the naïve transcript sets and the peptide
modules.
From the PCT set, eight of ten of themost significant GO terms
were also found in the bipartite module graph results. The two
that were not included were “regulation of actin filament length”
(adj. p-value 1.07e-04) and “regulation of actin filament poly-
merization” (adj. p-value 3.96e-04). Enrichment in the NCT set
showed one term that was also found in the bipartite module
graph, and two terms, including “xenobiotic metabolic process”
(adj. p-value 7.77e-03) and “response to xenobiotic stimulus”
(adj. p-value 1.29e-02), which were not.
The module level organization provided more significance
in enrichment tests compared to the naïve results. In pep-
tide modules, the most significant results were found in pep-
tide module 7 (not part of the module-graph) for GO terms
“cellular component biogenesis” (adj. p-value 1.94e-17), “cel-
lular macromolecular complex assembly” (adj. p-value 2.47e-
17) and “nucleosome assembly” (adj. p-value 8.29e-12) where
15 of 36 Entrez IDs were present. In the NCP results, where
the expression profile is negatively correlated with pathol-
ogy, no GO terms were significantly enriched, whereas in
the module-graph, there were sixteen significantly enriched
GO terms.
On the module level, highly ranked members (by module cen-
trality), showed little overlap across data types in terms of shared
Entrez IDs, even in the presence of significant module mem-
bership overlap (Supplementary Tables 1 and 2). Regardless, we
found that significant GO term enrichment was observed to
be overlapping across the data types. By utilizing the module
sub-graph, the most central members were functionally com-
pared, producing potentially novel connections to investigate. An
example was found in the module sub-graph including tran-
script module 4 and peptide modules 12 and 13 (See Figure 4).
The most central members (r > 0.8) enriched the same GO
terms, and in taking the union across modules, each data
type brings unique, and functionally related, members to the
analysis.
DISCUSSION
In this work, a new strategy for data integration has been devel-
oped that leverages existing network inference methodology for
transcriptomics and more recent extensions in proteomics. The
method was applied to infection time course data to examine
both the individual networks and the bipartite module graph with
regard to phenotypic correlation and functional enrichment, as
well as to provide integrated prioritization across data types.
Information needed to construct the bipartite module graph
included membership overlaps, summary eigenvector corre-
lations and common correlations to phenotype. The strong
correlations between module eigenvectors highlights the bio-
logical organization observed across data types. Given that
a large portion of peptides and transcripts, mapping to
the same Entrez ID, are essentially uncorrelated, it is strik-
ing to observe the modularity in our inferred networks,
and the strong connection between a subset of the mod-
ules. Effectively, this can provide the foundation of a true
multi-omic signature of SARS-CoV viral infection that may
have relation to other viral respiratory infections as well.
Additionally, this provides a perspective on modularity in the
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FIGURE 4 | An increase in the number of entities mapped to GO terms
using the union of module members within a module sub-graph.
Enrichment was performed using only the module members with
correlations to the module eigenvector greater than 0.8, these GO terms
were all in the top 5 most significant after GO term enrichment within each
module, and, after taking the union, they were still in the top 5 most
significant. Adjusted p-values for all modules can be found in
Supplementary Table 1.
proteome and its relationship to the module structure of the
transcriptome.
Initially modeling each data type individually offers a high
degree of flexibility in the analysis. In co-expression network
construction, one has choices about correlation type or met-
ric for association between nodes in the network, how or
whether to scale the associations, and how to cluster for mod-
ule discovery. Additionally, there are questions of normaliza-
tion and missing data that can affect on the downstream
network structure. These parameters can be separately tuned
in order to produce optimal independent networks on data
types, which can be used to produce integrated module graphs.
Generating well-formed, independent networks should improve
the odds of successful integration since they each more accu-
rately reflect the underlying biology. Without treating different
data sources independently, it is possible that the inherent noise
found in biological data would obscure patterns linking data
types.
In the correlation of expression profiles across data types,
there was a large degree of uncorrelated peptides and tran-
scripts, which has been previously observed (Ghazalpour et al.,
2011). Additionally, there are peptides and transcripts, which
are both correlated to phenotype, but are anti-correlated across
data types. The apparent disconnect between data types makes
interpretation difficult. The naïve ranked list is expected to be
less ordered compared to within-module rankings. This is seen
in the fact that for NCP, the naïve method returned no signifi-
cant enrichment results, while the module level results did show
significance. Compared to the naïve ranking approach, the mod-
ule level analysis avoided the problem of uncorrelated peptides
and transcripts, by connecting modules using a set of metrics,
rather than simple Entrez ID mapping. Additionally, the module
organization returned considerably more significant enrichment
results, and also showed more functional overlap across data
types.
One of the most difficult aspects of data integration can be
the annotation of highly heterogeneous data sets, connecting the
transcript and peptide to their correct source gene for instance.
For transcripts, this annotation is more straightforward since
microarray probes have been designed specifically to avoid degen-
eracy among genes and have relatively good documentation. On
the other hand, given a peptide, it can be quite difficult to deter-
mine what gene it ultimately resulted from. Our knowledge of
the proteome is still rapidly expanding, directly affecting our
peptide-transcript integration solution. As proteomics technolo-
gies improve, however, the intersection between the proteome
and transcriptome will continue to grow, improving our inte-
grated models, and our understanding of the cell.
In this work, we have provided a strategy for integrated analy-
sis in order to shed light on complex biology.With these methods,
it is possible to learn novel and biologically relevant information
about the relationship between the host and pathogen, but more
generally between the transcriptome and the proteome. This work
should prove to be platform independent, allowing the use of
RNAseq (see Iancu et al., 2012b) or other forms of proteomic
data. This can then be used to inform systems-level prioritiza-
tion for the subsequent perturbation and validation experiments,
allowing the full realization of systems based approaches.
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Supplementary Table 1 | Shows the top ten enriched GO terms for each
module sub-graph. The tables correspond to the module sub-graphs in
Figures 1, 3, and 4. Also contains the GO enrichment results for the Naïve
comparison.
Supplementary Table 2 | Shows the top ten entities by correlation with
the module summaries (ME, module eigenvector). The second column
shows the correlation with the Overall-total-score phenotype describing
the level of lung pathology. The tables correspond to the module
sub-graphs in Figures 1, 3, and 4.
Supplementary Table 3 | The mouse phenotype for experiment SM001, for
both mocks and infected mice. Pathological variables are given along with
viral dosages (Dose), day of tissue sampling post infection (Day), Mouse
ID (RepName).
Supplementary Figure 1 | Pearson correlations between transcript module
eigenvector summaries and mouse phenotypes. In rows, each module is
labeled as ME_followed by the module ID number.
Supplementary Figure 2 | Pearson correlations between peptide module
eigenvector summaries and mouse phenotypes. In rows, each module is
labeled as ME_ followed by the module ID number.
Supplementary Figure 3 | Pearson correlations between peptide module
eigenvector summaries and transcript module summaries. Each module is
labeled as ME_ followed by the module ID number.
Supplementary Figure 4 | Points are composed of peptide-transcript pairs,
where each entity maps to the same Entrez ID. The x and y axis are
correlations with the overall pathology phenotype, while the size and hue
indicates correlation across the data types. Blue indicates a positive
correlation while red shows a negative correlation.
Transcript_Module_Contents. A large table with columns:
Probe ID (the transcript probe), Module (the assigned mod-
ule), MM1 to MM6 (correlations with module eigenvectors),
p.MM1 to p.MM6 (p-values for each correlation), and then cor-
relations with phenotype variables, and p-values for phenotype
correlations.
Peptide_Module_Contents. A large table with columns:
Peptide ID, Module (the assigned module), MM1 to MM14
(correlations with module eigenvectors), p.MM1 to p.MM14
(p-values for each correlation), and then correlations with phe-
notype variables, and p-values for phenotype correlations.
Supplementary_Network_Results. A brief account of peptide
and transcript networks in terms of module sizes and module-
significance permutation tests. Also shown are module overlap
sizes with permutation test results, and the pairwise module
prioritization results for each phenotype.
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